輸入代號或公司名稱後按 Enter
8432

東生華

+0.15 (+0.30%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
50.0023成交張數11.49本益比1.36股價淨值比5.22%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q21.1975.0%4.360.4613.9%3.17%12.13%
2026Q11.0127.9%3.850.3913.6%2.65%10.25%
2025Q40.62148.0%3.630.246.7%1.65%9.83%
2025Q31.5421.3%3.260.5913.9%4.23%8.79%
2025Q20.6888.9%2.990.269.7%1.91%8.67%
2025Q10.79-26.2%2.670.3010.6%2.18%7.65%
2024Q40.25-40.5%2.950.103.3%0.69%9.05%
2024Q31.27188.6%3.120.4912.5%3.58%9.64%
2024Q20.36-23.4%2.290.145.9%1.09%7.40%
2024Q11.07282.1%2.400.4120.4%3.43%7.80%
2023Q40.42100.0%1.610.163.7%1.48%5.70%
2023Q30.44-6.4%1.400.1713.6%1.57%5.02%
2023Q20.4711.9%1.430.1814.4%1.69%5.19%
2023Q10.28-45.1%1.380.119.1%0.99%4.87%
2022Q40.21-44.7%1.610.086.5%0.75%5.75%
2022Q30.4780.8%1.780.1816.3%1.72%6.35%
2022Q20.4223.5%1.570.1614.8%1.51%5.60%
2022Q10.51104.0%1.490.1916.1%1.78%5.09%
2021Q40.382.7%1.230.1413.5%1.33%4.26%
2021Q30.26-35.0%1.220.1010.0%0.91%4.26%
2021Q20.3461.9%1.360.1312.4%1.17%4.79%
2021Q10.25-59.7%1.230.109.5%0.86%4.34%
2020Q40.37164.3%1.600.1411.4%1.28%5.47%
2020Q30.40-66.7%1.370.1615.5%1.40%4.73%
2020Q20.21-4.5%2.170.088.9%0.75%7.59%
2020Q10.62-6.1%2.180.2417.9%2.17%7.52%
2019Q40.14-41.7%2.220.054.5%0.48%7.60%
2019Q31.20400.0%2.320.4635.2%4.18%7.92%
2019Q20.2237.5%1.360.087.1%0.75%4.68%
2019Q10.66-23.3%1.300.2518.4%2.20%4.13%
2018Q40.24-38.5%1.500.098.1%0.82%5.10%
2018Q30.24-50.0%1.650.098.3%0.82%5.49%
2018Q20.16-67.3%1.890.064.4%0.52%6.10%
2018Q10.86160.6%2.220.3322.2%2.77%6.37%
2017Q40.3985.7%1.690.1512.5%1.28%5.00%
2017Q30.48700.0%1.510.1814.7%1.52%4.71%
2017Q20.49-74.9%1.090.1914.9%1.41%3.28%
2017Q10.33-77.4%2.550.1311.1%0.87%7.08%
2016Q40.213.680.086.0%0.57%
2016Q30.060.022.4%0.19%